Averaged across the five tumor domains, ~58% of cells were SOX10+ tumor cells whereas 42% were lymphocytes, myeloid cells, and stromal cells of various types (Fig. 2b–d; Supplementary Fig. 3a). This evidence concerns the gene SOX10 and neoplasm.